Search Browse Earnings

Arcus Biosciences, Inc. — SlamSEC

Arcus Biosciences, Inc.

NYSE:RCUS

Pharmaceutical Preparations·HAYWARD, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$37.0M

-2.6% YoY

FY 2025

Adj. EBITDA

-$332.0M

-897.3% margin

FY 2025

Net Income

-$307.0M

-829.7% margin

FY 2025

EPS (Diluted)

-$4.15

FY 2025

Stock Price

$23.43

+6.0%

2026-03-09

52W Range

$6.50 – $26.40

P/E Ratio

-5.6x

Market Cap

$2.9B

Cash

$150.0M

FY 2025

Total Debt

$48.0M

FY 2025

Net Cash

$102.0M

FY 2025

Enterprise Value

$2.8B

Debt / EBITDA

0.3x

FY 2025

EV / EBITDA

-8.5x

Employees

—

CEO

Rosen Terry J

CFO

Goeltz Ii Robert C.